PlasmOnCo's hydrogel scaffolds are designed for precise interaction with the cellular microenvironment, enabling unprecedented control over biological responses at the site of disease.
Modulating Biological Responses at the Cellular Boundary
From fundamental physics to translational oncology, our therapeutic platforms bridge laboratory discovery with human impact, accelerating the development of advanced cancer therapeutics.
Transforming Cancer Care
Our engineered oncology scaffolds offer a new paradigm for treatment, focusing on precision, efficacy, and patient well-being.
Localized Drug Delivery
Tissue Regeneration
Reduced Systemic Toxicity
Enhance therapeutic concentration directly at the tumor site, maximizing efficacy while sparing healthy tissues.
Support post-treatment healing and tissue repair, leveraging biomaterial properties for improved patient outcomes.
Minimize adverse effects associated with conventional treatments through targeted, high-precision therapeutic retention.
We invite clinical researchers, clinicians & pharmaceutical partners to evaluate our platform and collaborate on the next generation of oncology solutions.